18. Hyperfraciionated and accelerated thoracic radiation therapy (HFXA/TRT) increased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy (ChT)

Ritsuho Komaki

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '18. Hyperfraciionated and accelerated thoracic radiation therapy (HFXA/TRT) increased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy (ChT)'. Together they form a unique fingerprint.

Medicine & Life Sciences